Artivion, Inc.
- Last sale
- Nov 12, 2026 · -3.73%
- Market cap
- $945.55M
- 48.79M shares
- Filings
- 1,043
Q3 2026+13.6% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−13.2% FY25 yoy
Q3 2026derived−92.4% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+21.4% FY25 yoy
- $945.55M
- —
- 2.0×
- 2.1×
- -4.69%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $441,330,000 | reported | |
| FY 2024 | 2024-12-31 | $388,537,000 | reported | |
| FY 2023 | 2023-12-31 | $354,004,000 | reported | |
| FY 2022 | 2022-12-31 | $313,789,000 | reported | |
| FY 2021 | 2021-12-31 | $298,836,000 | reported | |
| FY 2020 | 2020-12-31 | $253,227,000 | reported | |
| FY 2019 | 2019-12-31 | $276,222,000 | reported | |
| FY 2018 | 2018-12-31 | $262,841,000 | reported | |
| FY 2017 | 2017-12-31 | $189,702,000 | reported | |
| FY 2016 | 2016-12-31 | $180,380,000 | reported | |
| FY 2015 | 2015-12-31 | $145,898,000 | reported | |
| FY 2014 | 2014-12-31 | $144,641,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2015 | $3.41M | — | $3.41M | $0.12 | 32.25M sh | +14.4% | 42.9% |
| FY2014 | $3.30M | $5.59M | $8.88M | $0.12 | 28.21M sh | +1.1% | 233.3% |
| FY2013 | $2.97M | $1.52M | $4.49M | $0.11 | 27.89M sh | +1.5% | 36.1% |
| FY2012 | $1.37M | $3.31M | $4.68M | $0.05 | 27.48M sh | −0.8% | 29.4% |
| FY2011 | — | $3.06M | $3.06M | — | 27.71M sh | — | 21.6% |
Segments
LineFY2025ShareChange
Medical devices$345.83M78%+19.2%
North America$221.74M50%+12.0%
EMEA$151.37M34%+15.1%
Preservation services$95.51M22%−2.9%
APAC$44.25M10%+18.9%
LATAM$23.97M5.4%+9.6%
Total$441.33M
Surgical & medical instruments & apparatus
Artivion, Inc. is the 31st largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
UFPTUFP Technologies Inc$602.8M19.5%11.3%$2.4BBVSBioventus Inc.$568.1M0.9%4.0%$916.3MATRCAtriCure, Inc.$534.5M14.9%2.1%$2.9BGKOSGlaukos Corp$507.4M32.3%37.0%$14.6B
AORTArtivion, Inc. (this company)$441.3M13.6%2.2%$945.5M
MDXGMimedx Group, Inc.$418.6M20.0%11.6%$471.3MARAYAccuray Inc$401.9M12.3%12.2%$376.1MTCMDTactile Systems Technology Inc$329.5M12.5%5.8%$601.3MANGOAngiodynamics Inc$320.2M9.5%11.5%$511.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Artivion, Inc. · CIK 784199 · Engraved from SEC EDGAR